1
|
Siciliano M, Tornambè S, Del Corvo M, Granai M, Mundo L, Sapienza M, Arcuri F, Mancini V, Santi R, Di Stefano G, Marafioti T, Ott G, Siebert R, Fend LQ, Fend F, Pileri S, Leoncini L, Lazzi S. EPSTEIN-BARR VIRUS ORCHESTRATE THE TUMOR MICROENVIRONMENT OF BURKITT LYMPHOMA. Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00206-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
2
|
Del Corvo M, Sapienza M, Siciliano M, Tornambè S, Mazzara S, Granai M, Mundo L, Arcuri F, Mancini V, Ferrara D, Ott G, Siebert R, Fend LQ, Fend F, Pileri S, Lazzi S, Leoncini L. “BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION”: NEITHER BURKITT-LYMPHOMA NOR DIFFUSE LARGE B-CELL LYMPHOMA. WHAT THE MICROENVIRONMENT TELLS US. Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00262-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
3
|
Matthews J, Prokoph N, Trigg R, Montes-Mojarro I, Fend F, Kenner L, Geoerger B, Johnston R, Murray M, Brugières L, Burke A, Turner SD. BRIGATINIB SHOWS PRECLINICAL PROMISE FOR AGGRESSIVE RELAPSED/REFRACTORY AK = LK-POSITIVE ALCL. Leuk Res 2022. [DOI: 10.1016/s0145-2126(22)00213-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
4
|
Schiemenz C, Lüken S, Klassen AM, Ranjbar M, Illerhaus G, Fend F, Heindl LM, Chronopoulos A, Grisanti S, Kakkassery V. [Clinical procedures for intraocular lymphomas]. Ophthalmologie 2022; 119:675-685. [PMID: 35925411 DOI: 10.1007/s00347-022-01651-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 04/21/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND The classification of intraocular lymphomas is based on their anatomical location. They are divided into uveal lymphomas with involvement of the choroid, ciliary body or iris and vitreoretinal lymphomas with isolated or combined involvement of the vitreous body and/or retina. Over the last decades it has become increasingly possible to work out the clinical and pathobiological features of the various subtypes, thereby reducing the diagnostic hurdles and creating improved treatment options. OBJECTIVE A summary of the various types of intraocular lymphoma in terms of clinical features, diagnostics, treatment and prognosis is given as well as recommendations for follow-up care. METHODS A selective literature search was carried out on the subject of intraocular lymphomas using PubMed and Google Scholar. RESULTS Intraocular lymphomas affect different structures, so that the symptoms can also be very different. The diagnostic spectrum ranges from typical ocular examination methods to sample biopsies with subsequent cytological, histological and molecular pathological processing. The treatment pillars available are percutaneous irradiation and intravitreal drug administration as local treatment and systemic treatment or a combination of systemic and local treatment. The prognosis depends mainly on the subtype of the lymphoma and the extent of the infestation when the diagnosis is confirmed. Even though some effective treatment options are now available, it has not yet been possible to significantly reduce the mortality rate. CONCLUSION Many different options are available for the diagnostics and treatment of intraocular lymphomas, which require close interdisciplinary cooperation. The further developments in the field of molecular pathology allow a faster and more accurate diagnosis and could open up new treatment options in the future.
Collapse
Affiliation(s)
- C Schiemenz
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
| | - S Lüken
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| | - A M Klassen
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| | - M Ranjbar
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| | - G Illerhaus
- Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin, Klinikum der Landeshauptstadt Stuttgart gKAöR | Standort Mitte, Katharinenhospital, Stuttgart, Deutschland
- Stuttgart Cancer Center, Tumorzentrum Eva Mayr-Stihl, Stuttgart, Deutschland
| | - F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
- Comprehensive Cancer Center, Tübingen-Stuttgart, Deutschland
| | - L M Heindl
- Zentrum für Augenheilkunde, Medizinische Fakultät und Universitätsklinikum Köln, Universität zu Köln, Köln, Deutschland
- Centrum für Integrierte Onkologie (CIO) Aachen-Bonn-Köln-Düsseldorf, Köln, Deutschland
| | - A Chronopoulos
- Augenklinik, Klinikum Ludwigshafen, Ludwigshafen, Deutschland
| | - S Grisanti
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| | - V Kakkassery
- Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| |
Collapse
|
5
|
Lipke N, Amend B, Montes Mojarro I, Fend F, Stenzl A, Aicher W, Harland N. Patient derived bladder cancer organoids – changes in growth and expression profile during longterm culture. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01151-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
6
|
Pollehne P, Montes Mojarro I, Schneider J, Amend B, Fend F, Stenzl A, Aicher W, Harland N. Patient derived bladder cancer organoids can be generated from rinsing urine -establishment, and evaluation of a simplified approach. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01150-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
von Stillfried S, Freeborn B, Windeck S, Boor P, Böcker J, Schmidt J, Tholen P, Röhrig R, Majeed R, Wienströer J, Bremer J, Weis J, Knüchel R, Breitbach A, Bülow RD, Cacchi C, Wucherpfennig S, Märkl B, Claus R, Dhillon C, Schaller T, Sipos E, Spring O, Braun G, Römmele C, Kling E, Kröncke T, Wittmann M, Hirschbühl K, Heppner FL, Meinhardt J, Radbruch H, Streit S, Horst D, Elezkurtaj S, Quaas A, Göbel H, Friemann J, Hansen T, Titze U, Lorenzen J, Reuter T, Woloszyn J, Baretton G, Hilsenbeck J, Meinhardt M, Pablik J, Sommer L, Holotiuk O, Meinel M, Esposito I, Crudele G, Seidl M, Mahlke N, Hartmann A, Haller F, Eichhorn P, Lange F, Amann KU, Coras R, Ingenwerth M, Rawitzer J, Schmid KW, Theegarten D, Gradhand E, Smith K, Wild P, Birngruber CG, Schilling O, Werner M, Acker T, Gattenlöhner S, Franz J, Metz I, Stadelmann C, Stork L, Thomas C, Zechel S, Ströbel P, Fathke C, Harder A, Wickenhauser C, Glatzel M, Matschke J, Krasemann S, Dietz E, Edler C, Fitzek A, Fröb D, Heinemann A, Heinrich F, Klein A, Kniep I, Lohner L, Möbius D, Ondruschka B, Püschel K, Schädler J, Schröder AS, Sperhake JP, Aepfelbacher M, Fischer N, Lütgehetmann M, Pfefferle S, Jonigk D, Werlein C, Domke LM, Hartmann L, Klein I, Schirmacher P, Schwab C, Röcken C, Langer D, Roth W, Strobl S, Rudelius M, Delbridge C, Kasajima A, Kuhn PH, Slotta-Huspenina J, Weichert W, Weirich G, Stock K, Barth P, Schnepper A, Wardelmann E, Evert K, Evert M, Büttner A, Manhart J, Nigbur S, Bösmüller H, Fend F, Granai M, Klingel K, Warm V, Steinestel K, Umathum VG, Rosenwald A, Vogt N, Kurz F. [Update on collaborative autopsy-based research in German pathology, neuropathology, and forensic medicine]. Pathologie (Heidelb) 2022; 43:101-105. [PMID: 36114379 PMCID: PMC9483541 DOI: 10.1007/s00292-022-01117-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Accepted: 08/30/2022] [Indexed: 01/02/2023]
Abstract
BACKGROUND Autopsies are a valuable tool for understanding disease, including COVID-19. MATERIALS AND METHODS The German Registry of COVID-19 Autopsies (DeRegCOVID), established in April 2020, serves as the electronic backbone of the National Autopsy Network (NATON), launched in early 2022 following DEFEAT PANDEMIcs. RESULTS The NATON consortium's interconnected, collaborative autopsy research is enabled by an unprecedented collaboration of 138 individuals at more than 35 German university and non-university autopsy centers through which pathology, neuropathology, and forensic medicine autopsy data including data on biomaterials are collected in DeRegCOVID and tissue-based research and methods development are conducted. More than 145 publications have now emerged from participating autopsy centers, highlighting various basic science and clinical aspects of COVID-19, such as thromboembolic events, organ tropism, SARS-CoV‑2 detection methods, and infectivity of SARS-CoV-2 at autopsy. CONCLUSIONS Participating centers have demonstrated the high value of autopsy and autopsy-derived data and biomaterials to modern medicine. The planned long-term continuation and further development of the registry and network, as well as the open and participatory design, will allow the involvement of all interested partners.
Collapse
Affiliation(s)
- Saskia von Stillfried
- Institut für Pathologie, Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland
| | - Benita Freeborn
- Institut für Pathologie, Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland
| | - Svenja Windeck
- Institut für Pathologie, Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland
| | - Peter Boor
- Institut für Pathologie, Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland ,Medizinische Klinik II (Nephrologie und Immunologie), Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland ,Elektronenmikroskopische Einrichtung, Universitätsklinik RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Deutschland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Vogelsberg A, Steinhilber J, Mankel B, Federmann B, Schmidt J, Montes-Mojarro IA, Hüttl K, Rodriguez-Pinilla M, Baskaran P, Nahnsen S, Piris MA, Ott G, Quintanilla-Martinez L, Bonzheim I, Fend F. [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]. Pathologe 2021; 42:122-128. [PMID: 34671837 DOI: 10.1007/s00292-021-01011-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 09/20/2021] [Indexed: 11/25/2022]
Abstract
BACKGROUND In situ follicular neoplasia (ISFN) is a t(14;18)(q32;q21)+ precursor lesion of follicular lymphoma (FL), which in turn can transform into diffuse large B‑cell lymphoma (DLBCL). For DLBCL that arise de novo, no precursor lesion is known. Given the high frequency of the t(14;18) translocation in de novo DLBCL as well, we investigated whether they can also arise from ISFN without FL as an intermediate step. OBJECTIVES To investigate the clonal evolution of ISFN to DLBCL - transformed from FL and de novo. MATERIALS AND METHODS Identification of ISFN lesions in patients with DLBCL was performed by BCL2 staining of reactive lymphoid tissues. ISFN and DLBCL were subsequently analyzed by fluorescence in situ hybridization, clonality analyses, sequencing of the t(14;18) breakpoint, and targeted next-generation sequencing. RESULTS 10 cases with paired ISFN and DLBCL samples were identified, 6 of which were de novo DLBCL and 4 transformed from FL. 3 DLBCL carried MYC-rearrangements in addition to the t(14;18) and were classified as high-grade B‑cell lymphoma (HGBL). The clonal relationship of ISFN and DLBCL/HGBL was confirmed for all cases. CREBBP, KMT2D, EZH2, TNFRSF14, and BCL2 were the genes most frequently mutated, with the distribution of private and shared mutations pointing to 2 different scenarios of clonal evolution. In most cases, DLBCL/HGBL, ISFN, and, if also present, FL had evolved divergently from a common progenitor, whereas linear evolution was less frequent. CONCLUSION We show for the first time that t(14;18)+ DLBCL/HGBL can arise directly from ISFN without FL as an intermediate step and that during this progression, divergent evolution is common.
Collapse
Affiliation(s)
- A Vogelsberg
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
| | - J Steinhilber
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - B Mankel
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - B Federmann
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - J Schmidt
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - I A Montes-Mojarro
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - K Hüttl
- Abteilung für Klinische Pathologie, Robert-Bosch-Krankenhaus und Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, Deutschland
| | | | - P Baskaran
- Zentrum für Quantitative Biologie, Eberhard Karls Universität Tübingen, Tübingen, Deutschland
| | - S Nahnsen
- Zentrum für Quantitative Biologie, Eberhard Karls Universität Tübingen, Tübingen, Deutschland
| | - M A Piris
- Abteilung für Pathologie, Fundación Jiménez Díaz, Madrid, Spanien
| | - G Ott
- Abteilung für Klinische Pathologie, Robert-Bosch-Krankenhaus und Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, Deutschland
| | - L Quintanilla-Martinez
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - I Bonzheim
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| |
Collapse
|
9
|
Harland N, Amend B, Lipke N, Brucker SY, Fend F, Herkommer A, Lensch H, Sawodny O, Schäffer TE, Schenke-Layland K, Tarín Sauer C, Aicher W, Stenzl A. [Organoids for the advancement of intraoperative diagnostic procedures]. Urologe A 2021; 60:1159-1166. [PMID: 34255127 DOI: 10.1007/s00120-021-01595-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/18/2021] [Indexed: 10/20/2022]
Abstract
In the context of cancer surgery, there is always a trade-off between oncological safety and preservation of function. This is especially true in pelvic surgery due to the close relationship to the pelvic floor muscles, blood supply and nerves. Currently, risk models, preoperative imaging, the surgeon's assessment, and the intraoperative frozen section serve as the basis for decision-making. New imaging techniques and standardization in frozen section have significantly improved this in recent years. However, limitations remain due to time delays as well as more difficult correct anatomical assignment in the follow-up. Alternative intraoperative techniques may overcome this limitation in the future. Patient-derived organoids have emerged as an important new research vehicle in recent years. They are based on tumor stem cells that, under special culture conditions, form three-dimensional replicas of the original tissue. This makes them ideally suited for testing individual system therapies but also as a validation technique for new intraoperative diagnostic procedures. The Research Training Group 2543/I, which is funded by the German Research Foundation, is researching the potential of new diagnostic methods in an interdisciplinary team regarding validation in addition to intraoperative frozen sections.
Collapse
Affiliation(s)
- N Harland
- Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland.
| | - B Amend
- Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland
| | - N Lipke
- Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland
| | - S Y Brucker
- Department für Frauengesundheit, Universitäts-Frauenklinik, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - A Herkommer
- Institut für Technische Optik, Universität Stuttgart, Stuttgart, Deutschland
| | - H Lensch
- Fachbereich Informatik, Computergrafik, Universität Tübingen, Tübingen, Deutschland
| | - O Sawodny
- Institut für Systemdynamik, Universität Stuttgart, Stuttgart, Deutschland
| | - T E Schäffer
- Institut für Angewandte Physik, Universität Tübingen, Tübingen, Deutschland
| | - K Schenke-Layland
- Department für Biomedical Engineering, Universität Tübingen, Tübingen, Deutschland.,NMI Naturwissenschaftliches und Medizinisches Institut, Universität Tübingen, Reutlingen, Deutschland
| | - C Tarín Sauer
- Institut für Systemdynamik, Universität Stuttgart, Stuttgart, Deutschland
| | - W Aicher
- Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland
| | - A Stenzl
- Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland
| |
Collapse
|
10
|
Frauenfeld L, Castrejon‐de‐Anta N, Ramis‐Zaldivar JE, Otto F, Streich S, Salmerón‐Villalobos J, Mayer A, Steinhilber J, Pinyol M, Mankel B, Bonzheim I, Fend F, Rimza L, Salaverria I, Campo E, Balagué O, Quintanilla‐Martinez L. TRIPLE POSITIVE (CD10+BCL6+MUM1+) DIFFUSE LARGE B‐CELL LYMPHOMAS IN ADULTS ARE A HETEROGENEOUS GROUP ENRICHED IN LARGE B‐CELL LYMPHOMAS WITH
IRF4
REARRANGEMENT. Hematol Oncol 2021. [DOI: 10.1002/hon.69_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- L. Frauenfeld
- University of Tübingen Institute for Pathology Tübingen Germany
| | | | - J. E. Ramis‐Zaldivar
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Barcelona Spain
| | - F. Otto
- University of Tübingen Institute for Pathology Tübingen Germany
| | - S. Streich
- University of Tübingen Institute for Pathology Tübingen Germany
| | - J. Salmerón‐Villalobos
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Barcelona Spain
| | - A. Mayer
- University of Tübingen Institute for Pathology Tübingen Germany
| | - J. Steinhilber
- University of Tübingen Institute for Pathology Tübingen Germany
| | - M. Pinyol
- Hospital Clínic de Barcelona Hematopathology Unit Barcelona Spain
| | - B. Mankel
- University of Tübingen Institute for Pathology Tübingen Germany
| | - I. Bonzheim
- University of Tübingen Institute for Pathology Tübingen Germany
| | - F. Fend
- University of Tübingen Institute for Pathology Tübingen Germany
| | - L. Rimza
- Mayo Clinic Division of Hematopathology Phoenix AZ USA
| | - I. Salaverria
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Barcelona Spain
| | - E. Campo
- Hospital Clínic de Barcelona Hematopathology Unit Barcelona Spain
| | - O. Balagué
- Hospital Clínic de Barcelona Hematopathology Unit Barcelona Spain
| | | |
Collapse
|
11
|
Steinke J, Nadalin S, Horger MS, Fend F, Frauenfeld L. [Rosai-Dorfman disease as a rare cause of a pancreatic mass]. Pathologe 2020; 42:231-234. [PMID: 33306139 DOI: 10.1007/s00292-020-00877-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 11/20/2020] [Indexed: 11/25/2022]
Abstract
The CT and MRI scans of a 70-year-old male patient revealed a mass in the pancreatic head and a 2.8-cm peripancreatic lymph node. Under steroid therapy the mass did not show regression. Finally, a pancreatoduodenectomy was performed. Histologically, Rosai-Dorfman disease (RDD) was diagnosed. RDD is a rare histiocytic disorder with usually nodal but sometimes also extranodal involvement. Herein we report a rare case of extranodal RDD with intrapancreatic localization.
Collapse
Affiliation(s)
- J Steinke
- Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland
| | - S Nadalin
- Klinik für Allgemein‑, Viszeral und Transplantationschirurgie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - M S Horger
- Diagnostische und Interventionelle Radiologie, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - F Fend
- Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.
| | - L Frauenfeld
- Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland
| |
Collapse
|
12
|
Groenen PJTA, Langerak AW, Fend F, van Krieken JHJM. Memento for interprofessional learning. Virchows Arch 2020; 477:755-756. [PMID: 32270299 PMCID: PMC7581595 DOI: 10.1007/s00428-020-02803-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 03/03/2020] [Accepted: 03/19/2020] [Indexed: 11/24/2022]
Abstract
The vast increase of technical, diagnostic, and treatment possibilities and deepened understanding of molecular biology has revolutionized diagnosis and treatment of cancer and thus has great impact on pathology. Different professionals are responsible for proper evaluation of the results and their translating into an accurate diagnosis and appropriate treatment. Next to expertise, a close interaction between clinical molecular biologists, pathologists, and oncologists is required; it is crucial that these professionals speak “the same language.” Key to this is communication skills and creating possibilities for collaboration in a meaningful context. Here, we present an interprofessional, educational workshop model and we describe the parameters that contribute to effective learning by specialists.
Collapse
Affiliation(s)
- Patricia J T A Groenen
- Dept. of Pathology, Radboud University Medical Centre Nijmegen, Geert Grooteplein Zuid 10, P.O Box 9101, 6500 HB, Nijmegen, The Netherlands.
| | - A W Langerak
- Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center, 3015 CN, Rotterdam, The Netherlands
| | - F Fend
- Institute of Pathology and Neuropathology, University Hospital Tuebingen/Eberhard-Karls-University, 72076, Tuebingen, Germany
| | - J H J M van Krieken
- Dept. of Pathology, Radboud University Medical Centre Nijmegen, Geert Grooteplein Zuid 10, P.O Box 9101, 6500 HB, Nijmegen, The Netherlands
| |
Collapse
|
13
|
Fend F. [Report by the haematopathology working group of the German Society of Pathology - annual meeting 2019]. Pathologe 2019; 40:382. [PMID: 31602504 DOI: 10.1007/s00292-019-00671-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- F Fend
- Institut für Pathologie und Neuropathologie, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.
| |
Collapse
|
14
|
Ott G, Klapper W, Feller AC, Hansmann ML, Möller P, Stein H, Rosenwald A, Fend F. [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]. Pathologe 2019; 40:157-168. [PMID: 30019203 DOI: 10.1007/s00292-018-0456-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
After 8 years, the WHO has now published the updated version of the 4th edition of the classification of hematopoietic and lymphoid tumors. This update provides a conceptual rewrite of existing entities as well as some new provisional entities and categories, particularly among the aggressive B‑cell lymphomas. Important new diagnostic categories include the high-grade B‑cell lymphomas, the large B‑cell lymphoma with IRF4 rearrangement, and the Burkitt-like lymphoma with 11q aberrations. Of particular importance, new concepts concerning the taxonomy and classification of early lymphoid lesions or precursor lesions are included, such as the in situ follicular neoplasia or the in situ mantle cell neoplasia. In addition, the concept of indolent lymphoproliferations, such as breast-implant-associated anaplastic large cell lymphoma and the indolent T‑cell lymphoproliferative disorder of the gastrointestinal tract, has been strengthened. Finally, diagnostic criteria for existing lymphoma entities have been refined.
Collapse
Affiliation(s)
- G Ott
- Abteilung für Klinische Pathologie, Robert-Bosch-Krankenhaus, und Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Auerbachstraße 110/112, 70376, Stuttgart, Deutschland.
| | - W Klapper
- Institut für Pathologie, Sektion Hämatopathologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland
| | - A C Feller
- Hämatopathologie Lübeck, Lübeck, Deutschland
| | - M L Hansmann
- Senckenberg Institut für Pathologie, Universitätsklinikum Frankfurt, Frankfurt, Deutschland
| | - P Möller
- Institut für Pathologie, Universitätsklinikum Ulm, Ulm, Deutschland
| | - H Stein
- Pathodiagnostik Berlin, Berlin, Deutschland
| | - A Rosenwald
- Pathologisches Institut und Comprehensive Cancer Center Mainfranken, Universität Würzburg, Würzburg, Deutschland
| | - F Fend
- Institut für Pathologie und Neuropathologie, Eberhard-Karls-Universität, Tübingen, Deutschland
| |
Collapse
|
15
|
Müller I, Ramis-Zaldívar J, Schmidt J, Egan C, Gonzalez-Farre B, Salmeron-Villalobos J, Mattern S, Szablewski V, Dojcinov S, Chott A, Copie-Bergman C, Bonzheim I, Campo E, Fend F, Jaffe E, Salaverria I, Quintanilla de Fend L. GENOME WIDE-ANALYSIS OF T(14;18)-NEGATIVE FOLLICULAR LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.102_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- I. Müller
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| | - J. Ramis-Zaldívar
- Hematopathology Unit; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona; Barcelona Spain
| | - J. Schmidt
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| | - C. Egan
- Laboratory of Pathology; Center for Cancer Research, National Cancer Institute, National Institutes of Health; Maryland United States
| | - B. Gonzalez-Farre
- Hematopathology Unit; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona; Barcelona Spain
| | - J. Salmeron-Villalobos
- Hematopathology Unit; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona; Barcelona Spain
| | - S. Mattern
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| | - V. Szablewski
- Département de Biopatholog Cellulaire et Tissulaire des Tumeurs; CHU Montpellier, Hôpital Gui De Chauliac; Montpellier France
| | - S. Dojcinov
- Department of Pathology; University Hospital of Wales; Cardiff United Kingdom
| | - A. Chott
- Institute of Pathology and Microbiology; Wilhelminenspital; Vienna Austria
| | - C. Copie-Bergman
- Department of Pathology; Henri Mondor Hospital, APHP, INSERM U955, Université Paris-Est; Créteil France
| | - I. Bonzheim
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| | - E. Campo
- Hematopathology Unit; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona; Barcelona Spain
| | - F. Fend
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| | - E.S. Jaffe
- Laboratory of Pathology; Center for Cancer Research, National Cancer Institute, National Institutes of Health; Maryland United States
| | - I. Salaverria
- Hematopathology Unit; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona; Barcelona Spain
| | - L. Quintanilla de Fend
- Institute of Pathology; University Hospital Tübingen, Eberhard-Karls-University of Tübingen; Tübingen Germany
| |
Collapse
|
16
|
Fend F, Quintanilla-Martinez L. [Clonal evolution of early lymphoproliferations]. Pathologe 2018; 39:247-249. [PMID: 30377786 DOI: 10.1007/s00292-018-0525-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
The identification and molecular characterisation of premalignant precursor lesions of lymphomas, such as monoclonal gammopathy of unknown significance (MGUS) and the so-called in situ lymphoproliferations, has made significant progress in the recent years. The in situ follicular neoplasia (ISFN), the best-characterised entity, is by definition not identifiable by morphology and represents a t(14;18)+ precursor lesion of follicular lymphoma with characteristic immunophenotype, low potential for progression, and already identifiable secondary genetic alterations. The use of high-throughput genetic techniques on microdissected tissues has generated novel insights into clonal evolution and biological progression of early lesions and documented that an isolated genetic analysis is insufficient to understand the complexity of proliferations.
Collapse
Affiliation(s)
- F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Eberhard-Karls-Universität Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.
| | - L Quintanilla-Martinez
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Eberhard-Karls-Universität Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland
| |
Collapse
|
17
|
Pasternak J, Kommoss S, Burkhardt F, Staebler A, Fend F, Schoenfisch B, Krämer B, Hartkopf AD, Wallwiener D, Brucker SY, Taran FA. Prognostic impact of pathological resection margin distance in primary squamous cell carcinoma of the vulva. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- J Pasternak
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - S Kommoss
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - F Burkhardt
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - A Staebler
- Institut für Pathologie und Neuropathologie, Tübingen, Deutschland
| | - F Fend
- Institut für Pathologie und Neuropathologie, Tübingen, Deutschland
| | - B Schoenfisch
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - B Krämer
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - AD Hartkopf
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - D Wallwiener
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - SY Brucker
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| | - FA Taran
- Universitätsfrauenklinik Tübingen, Tübingen, Deutschland
| |
Collapse
|
18
|
Klapper W, Fend F, Feller A, Hansmann ML, Möller P, Stein H, Rosenwald A, Ott G. [Aggressive B‑cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017]. Pathologe 2018; 40:152-156. [PMID: 29666909 DOI: 10.1007/s00292-018-0440-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The update of the 4th edition of the WHO classification for hematopoietic neoplasms introduces changes in the field of mature aggressive B‑cell lymphomas that are relevant to diagnostic pathologists. In daily practice, the question arises of which analysis should be performed when diagnosing the most common lymphoma entity, diffuse large B‑cell lymphoma. We discuss the importance of the cell of origin, the analysis of MYC translocations, and the delineation of the new WHO entities of high-grade B‑cell lymphomas.
Collapse
Affiliation(s)
- W Klapper
- Institut für Pathologie, Sektion Hämatopathologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, Haus 14, 24105, Kiel, Deutschland.
| | - F Fend
- Institut für Pathologie und Neuropathologie, Eberhard Karls Universität Tübingen, Tübingen, Deutschland
| | - A Feller
- Hämatopathologie Lübeck, Lübeck, Deutschland
| | - M L Hansmann
- Dr. Senckenbergisches Institut für Pathologie, Universitätsklinikum Frankfurt, Frankfurt, Deutschland
| | - P Möller
- Institut für Pathologie, Universitätsklinikum Ulm, Ulm, Deutschland
| | - H Stein
- Pathodiagnostik Berlin, Berlin, Deutschland
| | - A Rosenwald
- Pathologisches Institut, Universität Würzburg, Comprehensive Cancer Center Mainfranken, Mainfranken, Deutschland
| | - G Ott
- Abteilung für Klinische Pathologie, Robert-Bosch-Krankenhaus, Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, Deutschland
| |
Collapse
|
19
|
Siegel-Axel D, Jaghutriz BA, Peter A, Machann J, Kovarova M, Ullrich S, Gerst F, Nadalin S, Sipos B, Königsrainer A, Schick F, Stefan N, Fend F, Haen S, Häring HU, Wagner R, Schleicher E. Human fat depots show distinct quantitative, qualitative and functional inter-individual differences. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- D Siegel-Axel
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - BA Jaghutriz
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - J Machann
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
- Institut für Diabetes-Forschung und Metabolische Erkrankungen (IDM) – Metabolic Imaging des Helmholtz-Zentrums München an der Universität Tübingen, Neuherberg, Germany
| | - M Kovarova
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Gerst
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - S Nadalin
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - B Sipos
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - A Königsrainer
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - F Schick
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
| | - N Stefan
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - S Haen
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - HU Häring
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - R Wagner
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - E Schleicher
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| |
Collapse
|
20
|
Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, Kovaleva V, Werner M, Bonzheim I, Fend F, Sperveslage J, Kaulich K, Zacher A, Reifenberger G, Köhrer K, Stepanow S, Lerke S, Mayr T, Aust DE, Baretton G, Weidner S, Jung A, Kirchner T, Hansmann ML, Burbat L, von der Wall E, Dietel M, Hummel M. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. Virchows Arch 2018; 472:557-565. [PMID: 29374318 PMCID: PMC5924673 DOI: 10.1007/s00428-017-2288-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Revised: 12/05/2017] [Accepted: 12/19/2017] [Indexed: 12/12/2022]
Abstract
The simultaneous detection of multiple somatic mutations in the context of molecular diagnostics of cancer is frequently performed by means of amplicon-based targeted next-generation sequencing (NGS). However, only few studies are available comparing multicenter testing of different NGS platforms and gene panels. Therefore, seven partner sites of the German Cancer Consortium (DKTK) performed a multicenter interlaboratory trial for targeted NGS using the same formalin-fixed, paraffin-embedded (FFPE) specimen of molecularly pre-characterized tumors (n = 15; each n = 5 cases of Breast, Lung, and Colon carcinoma) and a colorectal cancer cell line DNA dilution series. Detailed information regarding pre-characterized mutations was not disclosed to the partners. Commercially available and custom-designed cancer gene panels were used for library preparation and subsequent sequencing on several devices of two NGS different platforms. For every case, centrally extracted DNA and FFPE tissue sections for local processing were delivered to each partner site to be sequenced with the commercial gene panel and local bioinformatics. For cancer-specific panel-based sequencing, only centrally extracted DNA was analyzed at seven sequencing sites. Subsequently, local data were compiled and bioinformatics was performed centrally. We were able to demonstrate that all pre-characterized mutations were re-identified correctly, irrespective of NGS platform or gene panel used. However, locally processed FFPE tissue sections disclosed that the DNA extraction method can affect the detection of mutations with a trend in favor of magnetic bead-based DNA extraction methods. In conclusion, targeted NGS is a very robust method for simultaneous detection of various mutations in FFPE tissue specimens if certain pre-analytical conditions are carefully considered.
Collapse
Affiliation(s)
- B Hirsch
- Campus Mitte, Institute of Pathology, Charité-University Medicine Berlin, Virchowweg 15, 10117, Berlin, Germany. .,German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
| | - V Endris
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Medicine Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany
| | - S Lassmann
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Breisacherstraße 115A, 79106, Freiburg, Germany
| | - W Weichert
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, Technical University Munich (TUM), Munich, Germany
| | - N Pfarr
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, Technical University Munich (TUM), Munich, Germany
| | - P Schirmacher
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Medicine Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany
| | - V Kovaleva
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Breisacherstraße 115A, 79106, Freiburg, Germany
| | - M Werner
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Breisacherstraße 115A, 79106, Freiburg, Germany
| | - I Bonzheim
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology and Neuropathology, University Hospital Tuebingen, Eberhard-Karls-University, Liebermeisterstraße 8, 72076, Tuebingen, Germany
| | - F Fend
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology and Neuropathology, University Hospital Tuebingen, Eberhard-Karls-University, Liebermeisterstraße 8, 72076, Tuebingen, Germany
| | - J Sperveslage
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology and Neuropathology, University Hospital Tuebingen, Eberhard-Karls-University, Liebermeisterstraße 8, 72076, Tuebingen, Germany
| | - K Kaulich
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Department of Neuropathology, Heinrich Heine University Duesseldorf and Biological and Medical Research Center (BMFZ), Genomics and Transcriptomics Laboratory, Heinrich Heine University Duesseldorf, 40225, Duesseldorf, Germany
| | - A Zacher
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Department of Neuropathology, Heinrich Heine University Duesseldorf and Biological and Medical Research Center (BMFZ), Genomics and Transcriptomics Laboratory, Heinrich Heine University Duesseldorf, 40225, Duesseldorf, Germany
| | - G Reifenberger
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Department of Neuropathology, Heinrich Heine University Duesseldorf and Biological and Medical Research Center (BMFZ), Genomics and Transcriptomics Laboratory, Heinrich Heine University Duesseldorf, 40225, Duesseldorf, Germany
| | - K Köhrer
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Department of Neuropathology, Heinrich Heine University Duesseldorf and Biological and Medical Research Center (BMFZ), Genomics and Transcriptomics Laboratory, Heinrich Heine University Duesseldorf, 40225, Duesseldorf, Germany
| | - S Stepanow
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Department of Neuropathology, Heinrich Heine University Duesseldorf and Biological and Medical Research Center (BMFZ), Genomics and Transcriptomics Laboratory, Heinrich Heine University Duesseldorf, 40225, Duesseldorf, Germany
| | - S Lerke
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany
| | - T Mayr
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany
| | - D E Aust
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany
| | - G Baretton
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany
| | - S Weidner
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, Ludwig-Maximilians University Munich, Thalkirchner Straße 36, 80337, Munich, Germany
| | - A Jung
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, Ludwig-Maximilians University Munich, Thalkirchner Straße 36, 80337, Munich, Germany
| | - T Kirchner
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Institute of Pathology, Ludwig-Maximilians University Munich, Thalkirchner Straße 36, 80337, Munich, Germany
| | - M L Hansmann
- German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.,Dr. Senckenberg Institute of Pathology, University Hospital, Goethe-University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany
| | - L Burbat
- Campus Mitte, Institute of Pathology, Charité-University Medicine Berlin, Virchowweg 15, 10117, Berlin, Germany.,German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
| | - E von der Wall
- Campus Mitte, Institute of Pathology, Charité-University Medicine Berlin, Virchowweg 15, 10117, Berlin, Germany.,German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
| | - M Dietel
- Campus Mitte, Institute of Pathology, Charité-University Medicine Berlin, Virchowweg 15, 10117, Berlin, Germany.,German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
| | - M Hummel
- Campus Mitte, Institute of Pathology, Charité-University Medicine Berlin, Virchowweg 15, 10117, Berlin, Germany.,German Cancer Consortium (DKTK) Partner Site, and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
| |
Collapse
|
21
|
Pasternak J, Wenz S, Taran FA, Krämer B, Hartkopf AD, Greif K, Wallwiener D, Fend F, Brucker SY, Staebler A, Kommoss S. Positive L1CAM immunohistochemistry in benign endometrial changes – potential pitfall in endometrial carcinoma pathology. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1606169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- J Pasternak
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - S Wenz
- Institut für Pathologie, Universitätsklinikum Tübingen, Tübingen
| | - FA Taran
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - B Krämer
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - AD Hartkopf
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - K Greif
- Institut für Pathologie, Universitätsklinikum Tübingen, Tübingen
| | - D Wallwiener
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - F Fend
- Institut für Pathologie, Universitätsklinikum Tübingen, Tübingen
| | - SY Brucker
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| | - A Staebler
- Institut für Pathologie, Universitätsklinikum Tübingen, Tübingen
| | - S Kommoss
- Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen
| |
Collapse
|
22
|
Knüchel-Clarke R, Fend F. [Benchmarking in pathology]. Pathologe 2017; 38:227. [PMID: 28589375 DOI: 10.1007/s00292-017-0302-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- R Knüchel-Clarke
- Institut für Pathologie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland.
| | - F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Eberhard-Karls-Universität Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.
| |
Collapse
|
23
|
Quintanilla-Fend L, Montes-Mojarro I, Steinhilber J, Lome-Maldonado C, Ramirez-Ibarguen A, Acosta B, Barrionuevo C, Duenas D, Narbaitz M, Bonzheim I, Fend F. MOLECULAR CHARACTERIZATION OF EXTRANODAL NATURAL KILLER (NK)/T-CELL LYMPHOMAS, NASAL TYPE FROM LATIN AMERICA. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - J. Steinhilber
- Institute of Pathology; University of Tuebingen; Tuebingen Germany
| | - C. Lome-Maldonado
- Department of Pathology; Instituto Nacional de Cancerologia; Tlalpan, Mexico City Mexico
| | - A.F. Ramirez-Ibarguen
- Department of Pathology; Instituto Nacional de Cancerologia; Tlalpan, Mexico City Mexico
| | - B. Acosta
- Department of Pathology; Instituto Nacional de Cancerologia; Tlalpan, Mexico City Mexico
| | - C. Barrionuevo
- Department of Pathology; Instituto Nacional de Enfermedades Neoplasicas; Surquillo Peru
| | - D. Duenas
- Department of Pathology; Instituto Nacional de Enfermedades Neoplasicas; Surquillo Peru
| | - M. Narbaitz
- Pathology; Instituto de Investigaciones Hematologicas, Academia Nacional de Medicina; Buenos Aires Argentina
| | - I. Bonzheim
- Institute of Pathology; University of Tuebingen; Tuebingen Germany
| | - F. Fend
- Institute of Pathology; University of Tuebingen; Tuebingen Germany
| |
Collapse
|
24
|
Schmidt J, Ramis-Záldivar J, Nadeu F, Gonzalez-Farre B, Navarro A, Dojcinov S, Rosenwald A, Ott G, Campo E, Fend F, Egan C, Jaffe E, Salaverria I, Quintanilla-Martinez L. INTEGRATIVE MUTATIONAL ANALYSIS OF PEDIATRIC-TYPE FOLLICULAR LYMPHOMA REVEALS TNFRSF14
AND MAP2K1
AS THE MOST FREQUENTLY MUTATED GENES. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J. Schmidt
- Institute of Pathology; University Hospital Tübingen; Tübingen Germany
| | - J. Ramis-Záldivar
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | - F. Nadeu
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | - B. Gonzalez-Farre
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | - A. Navarro
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | - S. Dojcinov
- Department of Pathology, All Wales Lymphoma Panel; University Hospital Wales; Cardiff UK
| | - A. Rosenwald
- Institute of Pathology; University of Würzburg; Würzburg Germany
| | - G. Ott
- Department of Clinical Pathology; Robert-Bosch Hospital; Stuttgart Germany
| | - E. Campo
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | - F. Fend
- Institute of Pathology; University Hospital Tübingen; Tübingen Germany
| | - C. Egan
- Laboratory of Pathology; National Cancer Institute; Bethesda USA
| | - E. Jaffe
- Laboratory of Pathology; National Cancer Institute; Bethesda USA
| | - I. Salaverria
- Institut d'Investigacions Biomèdiques August Pi iSunyer; Hospital Clínic; Barcelona Spain
| | | |
Collapse
|
25
|
Wagner R, Machann J, Guthoff M, Nawroth PP, Nadalin S, Saleem MA, Heyne N, Königsrainer A, Fend F, Schick F, Fritsche A, Stefan N, Häring HU, Schleicher E, Siegel-Axel DI. The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A. Sci Rep 2017; 7:2261. [PMID: 28536464 PMCID: PMC5442123 DOI: 10.1038/s41598-017-02210-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Accepted: 04/06/2017] [Indexed: 02/06/2023] Open
Abstract
Renal sinus fat (RSF) is a perivascular fat compartment located around renal arteries. In this in vitro and in vivo study we hypothesized that the hepatokine fetuin-A may impair renal function in non alcoholic fatty liver disease (NAFLD) by altering inflammatory signalling in RSF. To study effects of the crosstalk between fetuin-A, RSF and kidney, human renal sinus fat cells (RSFC) were isolated and cocultured with human endothelial cells (EC) or podocytes (PO). RSFC caused downregulation of proinflammatory and upregulation of regenerative factors in cocultured EC and PO, indicating a protective influence of RFSC. However, fetuin-A inverted these benign effects of RSFC from an anti- to a proinflammatory status. RSF was quantified by magnetic resonance imaging and liver fat content by 1H-MR spectroscopy in 449 individuals at risk for type 2 diabetes. Impaired renal function was determined via urinary albumin/creatinine-ratio (uACR). RSF did not correlate with uACR in subjects without NAFLD (n = 212, p = 0.94), but correlated positively in subjects with NAFLD (n = 105, p = 0.0005). Estimated glomerular filtration rate (eGRF) was inversely correlated with RSF, suggesting lower eGFR for subjects with higher RSF (r = 0.24, p < 0.0001). In conclusion, our data suggest that in the presence of NAFLD elevated fetuin-A levels may impair renal function by RSF-induced proinflammatory signalling in glomerular cells.
Collapse
Affiliation(s)
- R Wagner
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - J Machann
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany
| | - M Guthoff
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany
| | - P P Nawroth
- German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| | - S Nadalin
- Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center, Tübingen, Germany
| | - M A Saleem
- Bristol Renal and Children's Renal Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| | - N Heyne
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany
| | - A Königsrainer
- Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center, Tübingen, Germany
| | - F Fend
- Institute of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany
| | - F Schick
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany
| | - A Fritsche
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - N Stefan
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - H-U Häring
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - E Schleicher
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - D I Siegel-Axel
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany. .,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany. .,German Center for Diabetes Research (DZD), Neuherberg, Germany.
| |
Collapse
|
26
|
Wagner R, Machann J, Guthoff M, Nadalin S, Nawroth P, Saleem MA, Stefan N, Schick F, Fend F, Fritsche A, Königsrainer A, Heyne N, Häring HU, Schleicher E, Siegel-Axel DI. Die ‚fettige Niere‘: Interaktionen von renalem Sinusfett mit der Fettleber beeinflussen die Zytokinexpression glomerulärer Zellen in vitro und die renale Funktion in Prädiabetikern. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- R Wagner
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - J Machann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - M Guthoff
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Nadalin
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - P Nawroth
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Neuherberg/München, Germany
| | - MA Saleem
- Bristol Royal Hospital for Children, Paediatric Renal Medicine, University of Bristol, Bristol, Germany
| | - N Stefan
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - F Schick
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie (Department), Allgemeine Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - A Fritsche
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Königsrainer
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - N Heyne
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - E Schleicher
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - DI Siegel-Axel
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
27
|
Fallier-Becker P, Vollmer JP, Wolburg H, Haen S, Steiner J, Noell S, Lehmann R, Fend F. Case report: Propofol-related infusion syndrome. Ultrastruct Pathol 2017. [DOI: 10.1080/01913123.2016.1270783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- P. Fallier-Becker
- Institute of Pathology and Neuropathology, University of Tuebingen, Tuebingen, Germany
| | - J. P. Vollmer
- Institute of Anaesthesiology, Stadtspital Triemli, Zürich, Switzerland
| | - H. Wolburg
- Institute of Pathology and Neuropathology, University of Tuebingen, Tuebingen, Germany
| | - S. Haen
- Institute of Pathology and Neuropathology, University of Tuebingen, Tuebingen, Germany
| | - J. Steiner
- Neurosurgical Clinics, University of Tuebingen, Tuebingen, Germany
| | - S. Noell
- Neurosurgical Clinics, University of Tuebingen, Tuebingen, Germany
| | - R. Lehmann
- Clinical Chemical Central Laboratory, University of Tuebingen, Tuebingen, Germany
| | - F. Fend
- Institute of Pathology and Neuropathology, University of Tuebingen, Tuebingen, Germany
| |
Collapse
|
28
|
Fend F. [Report on the meeting of the Hematopathology Working Group]. Pathologe 2016; 37:235-236. [PMID: 27613301 DOI: 10.1007/s00292-016-0218-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Affiliation(s)
- F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Eberhard-Karls-Universität, Liebermeisterstr. 8, 72076, Tübingen, Deutschland.
| |
Collapse
|
29
|
Kommoss F, Grevenkamp F, Taran FA, Fend F, Brucker S, Wallwiener D, Schönfisch B, Lax S, Kommoss F, Staebler A, Kommoss S. L1CAM als wichtiger Prognosefaktor für Endometriumkarzinome mit niedrigem/intermediärem Risikoprofil. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
30
|
Grevenkamp F, Kommoss FKF, Kommoss FGM, Lax S, Fend F, Wallwiener D, Schönfisch B, Krämer B, Brucker S, Taran FA, Staebler A, Kommoss S. Stellenwert einer spezialisierten gynäkopathologischen Zweitbegutachtung in der Behandlung des Endometriumkarzinoms. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
31
|
Gerst F, Wagner R, Panse M, Siegel-Axel D, Ordelheide A, Stefan N, Sipos B, Fend F, Nadalin S, Königsrainer A, Häring HU, Ullrich S. Charakterisierung des „fettigen“ Pankreas: Beeinflussen Adipozyten und Immunzellen die Insel? DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
32
|
Siegel-Axel DI, Gerst F, Panse M, Wagner R, Machann J, Stefan N, Schmidt U, Schreiner B, Sipos B, Fend F, Nadalin S, Königsrainer A, Häring HU, Ullrich S. Interaktionen des „fettigen“ Pankreas mit der Fettleber: Unterschiedliche Effekte von Fetuin-A auf die durch Prädipozyten und Adipozyten vermittelte pankreatische Inflammation. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
De Colle C, Menegakis A, Mueller A, Yaromina A, Hennenlotter J, Stenzl A, Scharpf M, Fend F, Ricardi U, Baumann M, Zips D. PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31677-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
34
|
Wietek B, Schulze Temming-Hanhoff P, Pawlowski J, Wiesinger B, Helms G, Vogel U, Hahn M, Röhm C, Fend F, Nikolaou K, Staebler A. Einfluss der pathologischen und molekularen Parameter auf die Größenbestimmung des reinen DCIS in der präoperativen MR-Mammografie und Mammografie. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Hetzel J, Böckeler M, Ehab A, Wagner R, Spengler W, Oberle A, Steger V, Bösmüller H, Fend F, Kanz L, Häntschel M. Molekulargenetische Charakterisierung des nicht-kleinzelligen Bronchialkarzinoms mittels Kryobiopsie – unterschätzten wir die EGFR Mutatiosrate? Pneumologie 2016. [DOI: 10.1055/s-0036-1572283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
36
|
Krugmann J, Sterlacci W, Veits L, Vieth M, Rieker RJ, Altmann T, Sokolowski T, Fend F. Aberrant CD68 expression is a rare pitfall in the diagnosis of primary amelanotic malignant melanoma in ascites fluid. Cytopathology 2015; 27:295-6. [PMID: 26407839 DOI: 10.1111/cyt.12269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- J Krugmann
- Institute of Pathology, Klinikum Bayreuth GmbH, Bayreuth, Germany
| | - W Sterlacci
- Institute of Pathology, Klinikum Bayreuth GmbH, Bayreuth, Germany
| | - L Veits
- Institute of Pathology, Klinikum Bayreuth GmbH, Bayreuth, Germany
| | - M Vieth
- Institute of Pathology, Klinikum Bayreuth GmbH, Bayreuth, Germany
| | - R J Rieker
- Institute of Pathology, University of Erlangen, Erlangen, Germany
| | - T Altmann
- Clinic for Haematology/Oncology, LMU München, Munich, Germany
| | | | - F Fend
- Institute of Pathology, University of Tübingen, Tübingen, Germany
| |
Collapse
|
37
|
|
38
|
Federmann B, Metzler G, Bonzheim I, Fend F. [Differential diagnostic specific skin infiltrates in chronic myelomonocytic leukemia]. Pathologe 2015; 36:494-7. [PMID: 26292933 DOI: 10.1007/s00292-015-0058-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
A 72-year-old male patient presented with multiple erythematous plaques on the lower arms, lower legs and feet. The patient suffered from rheumatoid arthritis and accompanying interstitial granulomatous dermatitis under treatment with tocilizumab. Several months prior to presentation a chronic myelomonocytic leukemia (CMML) had been diagnosed. The skin biopsy showed a perivascular infiltration of medium-sized cells with positivity for CD123, CD303 and CD4 with a low proliferation activity so that a diagnosis of a CMML-associated proliferation of plasmacytoid dendritic cells was made. The differential diagnosis of specific cutaneous infiltrates in CMML is discussed.
Collapse
Affiliation(s)
- B Federmann
- Institut für Pathologie und Neuropathologie, Comprehensive Cancer Center und Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland,
| | | | | | | |
Collapse
|
39
|
Affiliation(s)
- F Fend
- Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen, Liebermeisterstrasse 8, 72076, Tübingen, Deutschland,
| |
Collapse
|
40
|
Haap M, Neumayer B, Kopp HG, Peter S, Haen S, Riessen R, Artunc F, Fend F, Kanz L, Müller MR. [Pulmonary infection in neutropenia]. Dtsch Med Wochenschr 2015; 140:426-7. [PMID: 25774734 DOI: 10.1055/s-0041-100947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
UNLABELLED MEDICAL HISTORY AND CLINICAL COURSE: A 42-year-old patient with hairy cell leukemia had been treated for 3 years by a hematologist in private practice. Initially the patient received 1 course of cladribine upon which the disease went into complete remission. 6 weeks ago a relapse was diagnosed and combination therapy with cladibrin and rituximab was initiated. Now the patient presented to the emergency room with shortness of breath and pain when breathing. INVESTIGATIONS, TREATMENT AND COURSE In the chest x-ray, patchy infiltrates and pleural effusions were found on both sides. The subsequently performed computed tomography showed bilateral compactions with an Halo suspicious for fungal infiltrates. Upon admission to the hospital, an empirical antibiotic therapy with clarithromycin and piperacillin/tazobactam was initiated, which was later escalated to meropenem and linezolid. Additionally, an antifungal therapy with voriconazole was started and later switched to liposomal amphotericin B. At his admission, a positive aspergillus antigen could be detected in the microbiological laboratory. Under antimycotic treatment the aspergillus antigen was repeatedly negative. The patient presented with pronounced cytopenias and after a switch of therapy to vemurafenib and filgrastim, the hematopoiesis could only be stimulated insufficiently. The patient was transferred to the intensive care unit three days after admission with severe respiratory failure. He died on day 8 after admission. AUTOPSY AND DIAGNOSIS: Diagnosis was consistent with relapse of hairy cell leukemia with positive BRAF mutation and a bone marrow infiltration > 80 %. Autopsy revealed a significant hepato-splenomegaly, a lack of erythro-, granulo- and thrombopoiesis. Clots interspersed with fungal hyphae were found in both lungs and an infarction of the spleen with evidence of fungal hyphae was detected. The cultural findings post mortem on yeast or mold were negative. CONCLUSION Patients with refractory hairy cell leukemia and prolonged neutropenia are at increased risk for systemic fungal infections. Therefore, prohylactic antimycotic therapy should be considered early in this group of patients. The therapeutic approach of vemurafenib in treatment-refractory hairy cell leukemia is promising and offers an additional treatment option. In the present case, the patient could unfortunately not be stabilized due to the septic complications.
Collapse
Affiliation(s)
- M Haap
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - B Neumayer
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - H-G Kopp
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - S Peter
- Abteilung für Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmonologie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - S Haen
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - R Riessen
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - F Artunc
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - F Fend
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - L Kanz
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| | - M R Müller
- Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen
| |
Collapse
|
41
|
Oberle A, Weyhern CHV, Horger M, Schuster T, Spengler W, Fend F, Kanz L, Hetzel J. Der diagnostische Algorithmus Interstitieller Lungenerkankungen wird durch transbronchiale Kryobiopsien im Vergleich zur Zangenbiopsie signifikant verbessert. Pneumologie 2015. [DOI: 10.1055/s-0035-1544627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
42
|
Bachmann C, Schmidt S, Staebler A, Fehm T, Fend F, Schittenhelm J, Wallwiener D, Grischke E. CNS metastases in breast cancer patients: prognostic implications of tumor subtype. Med Oncol 2014; 32:400. [PMID: 25433950 DOI: 10.1007/s12032-014-0400-2] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2014] [Accepted: 11/21/2014] [Indexed: 11/25/2022]
Abstract
Development of brain metastases (BM) in breast cancer leads to limited survival. The therapeutical options are limited. There are less data about the risk factors and prognostic importance in BM. Objective is to investigate predictors of central nervous system metastases and outcome after diagnosis of BM according to tumor subtype. Based on medical records, 80 consecutive patients with primary non-metastatic operable breast cancer, treated at Department of Gynecology, University of Tübingen, and who developed BM during follow-up, were retrospectively analyzed. Clinicopathological parameters and their prognostic impact were evaluated. A node involvement (40 %), ER/PR negative (53.75 vs. 61.25 %), triple negative (28.75 %) and HER2+ status (40 %) were associated with BM. BM in breast cancer patients lead to a shortened survival. In cerebral metastatic breast cancer patients with HER2-negative and triple-negative, patients had significant shorter survival after detection of BM compared with HER2-positive and non-triple-negative patients (p = 0.001; p = 0.03). Risk of BM varies significantly by subtype. Understanding the biology of metastases can help categorize patients into prognostically useful categories and tailor treatment regimens for individual patients. Prospective clinical trials would be required for evaluating the potential role of screening for asymptomatic BM and of treatment of triple-negative patients.
Collapse
Affiliation(s)
- C Bachmann
- Department of Gynecology, University of Tübingen, Calwer Str. 7, 72070, Tübingen, Germany,
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Zaby K, Staebler A, Taran A, McConechy M, Rozenberg N, Huntsman D, Gilks B, Anglesio M, Brucker S, Fend F, Kommoss F, Wallwiener D, Kommoss S. Diagnostik adulter Granulosazelltumoren unter Berücksichtigung aktueller Forschungsergebnisse. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
44
|
Grevenkamp F, Kommoss F, Taran FA, Lax S, Kommoss F, Wallwiener D, Brucker S, Fend F, Kommoss S, Staebler A. Konsensuspanel zur histopathologische Begutachtung von Endometriumkarzinomen: Klinische Bedeutung und Stellenwert im Rahmen translationaler Forschungsprojekte. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
45
|
Kommoss F, Grevenkamp F, Fend F, Taran FA, Brucker S, Wallwiener D, Kommoss F, Lax S, Staebler A, Kommoss S. L1CAM-Immunhistochemie: Prüfung einer vielversprechenden Option im Management früher Typ 1 Endometriumkarzinome. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
46
|
|
47
|
Mollweide A, Kirchberger D, Burdach S, Kremer M, Fend F, Maneck M, Blochberger I, Klein C, Richter G. MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma. Klin Padiatr 2014. [DOI: 10.1055/s-0034-1371099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
48
|
Bosse K, Ott C, Biegner T, Fend F, Siegmann-Luz K, Wallwiener D, Hahn M. 23-Year-Old Female with an Inflammatory Myofibroblastic Tumour of the Breast: A Case Report and a Review of the Literature. Geburtshilfe Frauenheilkd 2014; 74:167-170. [PMID: 24741129 DOI: 10.1055/s-0033-1360185] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2013] [Revised: 12/01/2013] [Accepted: 12/03/2013] [Indexed: 01/13/2023] Open
Abstract
Purpose: Inflammatory myofibroblastic tumours (IMT) are a subcategory of inflammatory pseudotumours (IPT). They arise most commonly in the abdominopelvic region, lung and retroperitoneum, but virtually any anatomical site may be involved. Predominantly children and adolescents are affected and there is a tendency for local recurrence. In the literature up to the present, 20 patients have been reported with an IPT/IMT of the breast. We would like to present another patient with this unusual tumour entity of the breast and discuss the literature. Patient and Examinations: A 23-year-old woman presented with a painless lump in her left breast. There was no history of breast cancer in her family. Sonography showed a hypoechoic heterogeneous solid mass with irregular margins. A core needle biopsy revealed a tumour of high cellularity and a densely collagenous background. Immunohistochemically, the spindle-shaped cells were immunoreactive to smooth muscle actin and ALK-1 protein. Additional FISH analysis proved ALK rearrangements on chromosome 2p23 leading to the diagnosis of an IMT. Wide surgical excision was performed with no evidence of local recurrence after 12 months. Conclusion: Three of the above mentioned 20 patients with IMT/IPT of the breast developed a recurrent tumour, none presented with distant metastasis. A significant recurrence rate of 15 % leads to a clinically and sonographically close follow-up in these patients.
Collapse
Affiliation(s)
- K Bosse
- Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen
| | - C Ott
- Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen
| | - T Biegner
- Institute of Pathology and Neuropathology, University Hospital of Tübingen, Tübingen
| | - F Fend
- Institute of Pathology and Neuropathology, University Hospital of Tübingen, Tübingen
| | - K Siegmann-Luz
- University Hospital of Tuebingen, Diagnostic and Interventional Radiology, Tübingen
| | - D Wallwiener
- Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen
| | - M Hahn
- Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen
| |
Collapse
|
49
|
Federmann B, Lauer UM, Haen S, Kilias A, Artunc F, Riessen R, Fend F, Haap M. [An unexpected cause of progressive hepatopathy - Case 2/2014]. Dtsch Med Wochenschr 2014; 139:378. [PMID: 24519115 DOI: 10.1055/s-0033-1360047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- B Federmann
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - U M Lauer
- Medizinische Klinik, Universitätsklinikum Tübingen
| | - S Haen
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - A Kilias
- Medizinische Klinik, Universitätsklinikum Tübingen
| | - F Artunc
- Medizinische Klinik, Universitätsklinikum Tübingen
| | - R Riessen
- Medizinische Klinik, Universitätsklinikum Tübingen
| | - F Fend
- Institut für Pathologie, Universitätsklinikum Tübingen
| | - M Haap
- Medizinische Klinik, Universitätsklinikum Tübingen
| |
Collapse
|
50
|
Adam P, Schraml C, Sipos B, Fend F. [Mesothelial proliferation in rectal cancer]. Pathologe 2014; 35:88-92. [PMID: 24496993 DOI: 10.1007/s00292-013-1880-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
In an epiphrenic lymph node of a 55 years old female patient who underwent surgical resection of a rectal adenocarcinoma epitheloid proliferations with papillary and solid growth pattern were seen additional to a metastasis of the carcinoma. Adjacent vessels contained similar infiltrates. Immunohistochemically a co-expression of pan-keratin, calretinin and WT1 was seen, suggestive for a diagnosis of a metastasis of a malignant mesothelioma. However, radiologic examination yielded no morphologic correlate to this suspicion. Further immunohistochemical work-up showed positivity for desmin, negativity for EMA, GLUT1, p53 and a low ki67-fraction of 2-3 %. Therefore, a final diagnosis of benign mesothelial proliferations disseminated into the lymph node and the adjacent vessels was made.
Collapse
Affiliation(s)
- P Adam
- Abteilung Allgemeine Pathologie und Pathologische Anatomie, Institut für Pathologie und Neuropathologie, Eberhard-Karls-Universität Tübingen, Liebermeisterstr. 8, 72076, Tübingen, Deutschland,
| | | | | | | |
Collapse
|